https://doi.org/10.1021/acsnano.6b06040
L
Lily Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
279
Papers
15.5K
Citations
60
h-index
132
i10-index
Lily Yang is an academic researcher. The author has contributed to research in topics: Nanoparticle-Based Drug Delivery & Nanoplatforms for cancer theranostics & Cancer Research and Treatments. The author has an h-index of 60, co-authored 238 publications.
ORCID: 0000-0003-2959-0094Papers by this author
worksDiverse Applications of Nanomedicine
2017 · ACS Nano · 1,319 citations
Cross-talk between Epidermal Growth Factor Receptor and Hypoxia-inducible Factor-1α Signal Pathways Increases Resistance to Apoptosis by Up-regulating Survivin Gene Expression
2006 · Journal of Biological Chemistry · 294 citations
https://doi.org/10.1074/jbc.m603414200
Development of Multifunctional Nanoparticles for Targeted Drug Delivery and Noninvasive Imaging of Therapeutic Effect
2009 · Current Drug Discovery Technologies · 249 citations
https://doi.org/10.2174/157016309787581066
Bupropion
2008 · Drugs · 142 citations
https://doi.org/10.2165/00003495-200868050-00011
Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles
2019 · Theranostics · 112 citations
https://doi.org/10.7150/thno.29964
Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells
2011 · Molecular Cancer Therapeutics · 102 citations
https://doi.org/10.1158/1535-7163.mct-10-0925
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat